Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1015 | 1015 | 1081 | 1238 | 1368 | 1861 |
Fund Return | 1.5% | 1.5% | 8.1% | 7.38% | 6.47% | 6.41% |
Place in category | 371 | 371 | 230 | 146 | 39 | 33 |
% in Category | 72 | 72 | 45 | 32 | 12 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Institutional | 88.37M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Retail Income | 136.41M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Z Income GBP | 667.28M | 1.50 | 7.39 | 6.42 | ||
UK Equity Income Fund Retail Accumu | 114.91M | 1.30 | 6.55 | 5.58 | ||
Select Fund Z Accumulation GBP | 989.45M | 8.04 | 7.99 | 9.80 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 4.54B | 5.82 | 8.22 | 6.86 | ||
TB Evenlode Income B Income | 3.33B | 0.66 | 7.02 | 8.54 | ||
UK Equity Income Fund Institutional | 88.37M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Retail Income | 136.41M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Retail Accumu | 114.91M | 1.30 | 6.55 | 5.58 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Imperial Brands | GB0004544929 | 6.91 | 1,757.00 | +0.49% | |
GSK plc | GB00BN7SWP63 | 5.66 | 1,576.50 | -0.44% | |
HSBC | GB0005405286 | 4.87 | 636.20 | -1.30% | |
Unilever | GB00B10RZP78 | 4.70 | 44.54 | +0.70% | |
Pearson | GB0006776081 | 4.41 | 991.40 | -0.24% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review